Gujarat Kidney And Super Speciality Limited (NSE:GKSL)
India · Delayed Price · Currency is INR 127.93
-0.48 (-0.37%)
At close: Jun 17, 2026
NSE:GKSL Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 820.13 | 402.42 | 47.74 | - | 7.86 | |
Revenue Growth (YoY) | 103.80% | 742.89% | - | - | -28.71% |
Cost of Revenue | 227.55 | 129.15 | 14.32 | - | 0.48 |
Gross Profit | 592.58 | 273.28 | 33.42 | - | 7.38 |
Selling, General & Admin | - | 4.32 | 0.61 | - | 0.15 |
Other Operating Expenses | 323.19 | 103.49 | 13.3 | 0.04 | 0.05 |
Operating Expenses | 370.18 | 140.71 | 17.11 | 0.04 | 5.94 |
Operating Income | 222.4 | 132.57 | 16.32 | -0.04 | 1.44 |
Interest Expense | -18.78 | -6.37 | -0.64 | -0.02 | -0.09 |
Interest & Investment Income | - | 1.15 | 0.02 | - | - |
Other Non Operating Income (Expenses) | 8.73 | -0.09 | -0.03 | - | - |
EBT Excluding Unusual Items | 212.35 | 127.26 | 15.67 | -0.06 | 1.35 |
Gain (Loss) on Sale of Assets | - | - | 7.02 | - | - |
Other Unusual Items | - | 0.4 | - | - | - |
Pretax Income | 212.35 | 127.65 | 22.68 | -0.06 | 1.35 |
Income Tax Expense | 44.23 | 32.66 | 5.54 | -0 | 0.36 |
Earnings From Continuing Operations | 168.12 | 94.99 | 17.14 | -0.06 | 0.98 |
Minority Interest in Earnings | -13.15 | -0.86 | - | - | - |
Net Income | 154.97 | 94.13 | 17.14 | -0.06 | 0.98 |
Net Income to Common | 154.97 | 94.13 | 17.14 | -0.06 | 0.98 |
Net Income Growth | 64.63% | 449.19% | - | - | 19.50% |
Shares Outstanding (Basic) | 62 | 51 | 35 | 35 | 35 |
Shares Outstanding (Diluted) | 62 | 51 | 35 | 35 | 35 |
Shares Change (YoY) | 22.01% | 45.75% | - | - | - |
EPS (Basic) | 2.49 | 1.85 | 0.49 | -0.00 | 0.03 |
EPS (Diluted) | 2.49 | 1.85 | 0.49 | -0.00 | 0.03 |
EPS Growth | 34.94% | 276.81% | - | - | 19.50% |
Free Cash Flow | -736.76 | 24.92 | 12.13 | 0 | 0.02 |
Free Cash Flow Per Share | -11.84 | 0.49 | 0.35 | - | 0.00 |
Gross Margin | 72.25% | 67.91% | 70.00% | - | 93.89% |
Operating Margin | 27.12% | 32.94% | 34.17% | - | 18.32% |
Profit Margin | 18.90% | 23.39% | 35.90% | - | 12.53% |
Free Cash Flow Margin | -89.83% | 6.19% | 25.40% | - | 0.30% |
EBITDA | 269.4 | 160.12 | 19.14 | 5.7 | 7.18 |
EBITDA Margin | 32.85% | 39.79% | 40.09% | - | 91.34% |
D&A For EBITDA | 47 | 27.56 | 2.83 | 5.74 | 5.74 |
EBIT | 222.4 | 132.57 | 16.32 | -0.04 | 1.44 |
EBIT Margin | 27.12% | 32.94% | 34.17% | - | 18.32% |
Effective Tax Rate | 20.83% | 25.58% | 24.44% | - | 26.90% |
Revenue as Reported | 828.86 | 403.97 | 54.78 | 0 | 7.86 |
Advertising Expenses | - | 2.26 | 0.54 | - | 0.15 |